Alzheimer’s Disease Pipeline

Opinion
Video

Key opinion leaders discuss the Alzheimer's disease pipeline and the numerous disease-modifying therapies under investigation.

Video content above is prompted by the following question:

  • Please provide an overview of robust Alzheimer’s pipeline and many disease modifying therapies under investigation.
  • Discuss novel and emerging treatments that are most advanced in clinical studies or have promising data:
    • Valiltramiprosate (ALZ-801,inhibits amyloid oligomer formation, oral)
    • ALN-APP (RNAi therapeutic)
    • Blarcamesine (sigma-1 and muscarinic receptors ligand)
Related Videos
Video 3 - 5 KOLs are featured in "Transitions of Care: Moving Spinal Muscular Atrophy Patients from Pediatric/Adolescent Care to Adult Clinics"
Video 3 - 5 KOLs are featured in "Presentation of Adult Spinal Muscular Atrophy in Clinics"
Video 2 - 5 KOLs are featured in "Natural History of Spinal Muscular Atrophy"
Video 1 - 5 KOLs are featured in "Clinical Features and Phenotypes of Spinal Muscular Atrophy"
A panel of 3 experts on Alzheimer's disease
A panel of 3 experts on Alzheimer's disease
A panel of 3 experts on Alzheimer's disease
Monica Verduzco-Gutierrez, MD
© 2024 MJH Life Sciences

All rights reserved.